Lysine

Lysine

SCHEMBL6151465

NCCCC[C@H](N)C(=O)O.NCCCC[C@H](N)C(=O)O.N[C@@H](COC(=O)[C@@H]1CCCN1)C(=O)O

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.49
DPP7 Q9UHL4 6/20 0.38
DPP4 P27487 4/20 0.38
DPP8 Q6V1X1 4/20 0.38
DPP9 Q86TI2 2/20 0.38
FAP Q12884 1/20 0.38
ARG2 P78540 4/20 0.33
ARG1 P05089 3/20 0.33
TLR2 O60603 2/20 0.33
ITGB3 P05106 1/20 0.32
ITGA2B P08514 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2043828 0.88 NOS2 (0.37) DPP7DPP4DPP8DPP9FAP
Lysine SCHEMBL15942522 0.88 GSR (0.47) GSRDPP7DPP4DPP8DPP9
Lysine SCHEMBL1537262 0.84 GSR (0.57) GSRDPP7DPP4DPP8DPP9
Lysine SCHEMBL4296375 0.84 GSR (0.57) GSRDPP7DPP4DPP8DPP9
Lysine SCHEMBL28079281 0.84 GSR (0.57) GSRDPP7DPP4DPP8DPP9
Lysine SCHEMBL23834597 0.84 GSR (0.57) GSRDPP7DPP4DPP8DPP9
Lysine SCHEMBL11660661 0.84 GSR (0.57) GSRDPP7DPP4DPP8DPP9
Lysine SCHEMBL1696608 0.84 GSR (0.57) GSRDPP7DPP4DPP8DPP9
Lysine SCHEMBL5227175 0.84 GSR (0.57) GSRDPP7DPP4DPP8DPP9
Proline SCHEMBL140698 0.84 TLR2 (0.34) DPP7DPP4DPP8DPP9FAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1513502-B1 COMBINATION THERAPY FOR RESPIRATORY DISORDERS OCKHAM BIOTECH LTD (GB) 2015-12-30 EP disclosed
EP-1513502-A1 COMBINATION THERAPY FOR RESPIRATORY DISORDERS University of Southampton (GB) 2005-03-16 EP disclosed
WO-2003068188-A1 COMBINATION THERAPY FOR RESPIRATORY DISORDERS UNIVERSITY OF SOUTHAMPTON (GB) 2003-08-21 WO disclosed